Purpose: The pharmacology, pharmacokinetics, clinical efficacy ... Pregabalin has demonstrated efficacy in the management of neuropathic pain associated with diabetic peripheral neuropathy ...

ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

QUTENZA ® is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN ...

QUTENZA ® is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and ...

has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and tolerability of QUTENZA® (capsaicin) 8% topical system in post-surgical neuropathic ...

has completed recruitment for the Phase III clinical trial AV001 ... 8% topical system in post-surgical neuropathic pain (PSNP) and if successful could support an extension of the U.S. label.